Does TACROLIMUS Cause Central nervous system lesion? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Central nervous system lesion have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.1% of all adverse event reports for TACROLIMUS.
122
Reports of Central nervous system lesion with TACROLIMUS
0.1%
of all TACROLIMUS reports
38
Deaths
98
Hospitalizations
How Dangerous Is Central nervous system lesion From TACROLIMUS?
Of the 122 reports, 38 (31.1%) resulted in death, 98 (80.3%) required hospitalization, and 31 (25.4%) were considered life-threatening.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
Which TACROLIMUS Alternatives Have Lower Central nervous system lesion Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB